--- title: "Psychemedics Corporation (PMDI.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/PMDI.US.md" symbol: "PMDI.US" name: "Psychemedics Corporation" industry: "醫療服務" --- # Psychemedics Corporation (PMDI.US) | Item | Detail | |------|--------| | Industry | 醫療服務 | | Location | 美股市場 | | Website | [www.psychemedics.com](https://www.psychemedics.com) | ## Company Profile Psychemedics Corporation 及其子公司在美國及國際上提供藥物濫用檢測和其他健康指標的測試服務,通過分析頭發樣本進行檢測。該公司採用行業認可的質譜技術進行篩查和確認,檢測的物質包括可卡因、大麻和 PCP;安非他命,包括搖頭丸、eve 和阿莫達非尼;阿片類藥物,如海洛因代謝物、嗎啡、氫可酮、氫嗎啡酮、羥考酮、羥嗎啡酮和可待因;合成大麻素,包括 K2、Spice 和 Blaze;苯二氮卓類藥物,包括 Xanax、Valium 和 Ativan;以及尼古丁、芬太尼及其類似物和酒精。其測試結果提供定量信息,能夠指示攝入藥物的大致數量,以及歷史數據,顯示個體在較長時間內的藥物使用模式... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-03-02T04:30:14.000Z **Overall: C (0.54)** **Industry**: Health Care Services | Metric | Value | |--------|-------| | Industry Ranking | 54 / 86 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -10.92% | | | Net Profit YoY | 55.20% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 1.97 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 10.10M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 19.68M | | **Multi Score**: C #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -31.54% | E | | Profit Margin | -9.45% | D | | Gross Margin | 36.07% | C | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -10.92% | E | | Net Profit YoY | 55.20% | B | | Total Assets YoY | -32.52% | E | | Net Assets YoY | -23.11% | E | #### Cash Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -1057.76% | E | | OCF YoY | -10.92% | E | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 1.91 | A | #### Debt Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 38.33% | B | ```chart-data:radar { "title": "Longbridge Financial Score - Psychemedics Corporation", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-31.54%", "rating": "E" }, { "name": "Profit Margin", "value": "-9.45%", "rating": "D" }, { "name": "Gross Margin", "value": "36.07%", "rating": "C" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "-10.92%", "rating": "E" }, { "name": "Net Profit YoY", "value": "55.20%", "rating": "B" }, { "name": "Total Assets YoY", "value": "-32.52%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-23.11%", "rating": "E" } ] }, { "name": "Cash", "grade": "E", "indicators": [ { "name": "Cash Flow Margin", "value": "-1057.76%", "rating": "E" }, { "name": "OCF YoY", "value": "-10.92%", "rating": "E" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "1.91", "rating": "A" } ] }, { "name": "Security", "grade": "B", "indicators": [ { "name": "Gearing Ratio", "value": "38.33%", "rating": "B" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | TalkSpace (US.TALK) | C | B | A | A | A | A | | 02 | 信諾保險 (US.CI) | B | B | A | D | B | B | | 03 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B | | 04 | 實驗美控 (US.LH) | B | C | B | C | B | B | | 05 | 奎斯特診療 (US.DGX) | B | B | B | C | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -5.43 | 48/79 | - | - | - | | PB | 1.97 | 30/79 | 2.74 | 2.52 | 2.15 | | PS (TTM) | 0.51 | 19/79 | 0.71 | 0.67 | 0.56 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/PMDI.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/PMDI.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/PMDI.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.